Jiangsu Recbio Technology Co., Ltd. (Stock Code: 2179) has issued a notice regarding its 2025 first extraordinary general meeting (EGM), scheduled for December 19, 2025, at 10:00 a.m. The venue will be the Conference Room on the third floor of Building G29, Standard Plant, China Medical City Phase 6, Medical High-tech District, Taizhou City, Jiangsu Province in the People’s Republic of China. Shareholders may attend in person or by proxy.
The official agenda includes one special resolution proposing the abolishment of the Supervisory Board and related amendments to the company’s Articles of Association. In addition, there are ordinary resolutions to vote on the proposed appointments of three individuals—Messrs. Xu Haoyu and Wei Qifang, as well as Ms. Wang Jing—to the Company’s Board of Directors. The meeting will also consider revisions to the Rules for the Management of Connected Transactions and amendments to the Working Procedures of the Independent Non-executive Directors.
Proxy forms and related identification requirements must be submitted according to the instructions provided in the notice. Shareholders are required to deliver relevant documents to the Company’s H Share Registrar or headquarters at least 24 hours prior to the meeting, and each attendee will be entitled to one vote per share owned. The announcement also reminds those who cannot attend in person to ensure their proxies are properly appointed and authorized by that deadline.
Comments